This investigational drug aims to reduce the number of eosinophils in the esophagus, thus reducing inflammation, pain and swallowing difficulties.

• Eosinophilic Esophagitis {EoE) is a chronic allergic/immunologic condition where white blood cells, called eosinophils, overpopulate and reside in the esophagus.
• Eosinophils can release harmful substances that cause inflammation.
• Chronic inflammation of the esophagus can lead to narrowing, leading to difficulty and/or pain when swallowing.

Study Benefits

• This investigational drug aims to reduce the number of eosinophils in the esophagus, thus reducing inflammation, pain and swallowing difficulties.

Study Volunteers Must Meet the Following Criteria

• Male or female
• Between ages of 18 and 75 years old
• Must have a previous documented diagnosis of EoE

Study Participant Expectations

• At the beginning and end of the study, we will ask you to undergo an esophageal biopsy to determine how many eosinophils are present in the tissue

Cost

• There is no cost to participate
• If you qualify, you will be compensated up to $625